MENU
+Compare
ADAG
Stock ticker: NASDAQ
AS OF
May 12, 04:00 PM (EDT)
Price
$1.70
Change
+$0.10 (+6.25%)
Capitalization
75.38M

ADAG Adagene Forecast, Technical & Fundamental Analysis

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies... Show more

ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADAG with price predictions
May 09, 2025

ADAG's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ADAG turned positive on April 30, 2025. Looking at past instances where ADAG's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where ADAG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 01, 2025. You may want to consider a long position or call options on ADAG as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADAG advanced for three days, in of 172 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADAG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADAG entered a downward trend on April 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADAG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.492) is normal, around the industry mean (14.703). P/E Ratio (0.000) is within average values for comparable stocks, (64.016). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.990). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (714.286) is also within normal values, averaging (254.016).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADAG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADAG is expected to report earnings to rise 10.34% to -31 cents per share on August 27

Adagene ADAG Stock Earnings Reports
Q2'25
Est.
$-0.32
Q4'24
Beat
by $0.18
Q2'24
Missed
by $0.03
Q4'23
Beat
by $0.96
Q3'23
Missed
by $0.04
The last earnings report on March 24 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 55.64K shares outstanding, the current market capitalization sits at 75.38M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Xinghu Street, Suzhou Industrial Park
Phone
+86 51287773632
Employees
174
Web
https://www.adagene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRMAX26.33N/A
N/A
Nationwide S&P 500 Index A
MSERX8.62N/A
N/A
MassMutual Small Cap Growth Eq R4
EILIX13.40N/A
N/A
Eaton Vance International Small-Cap I
GCIFX14.88N/A
N/A
Green Century MSCI Intl Indx Instl
JEPCX13.83N/A
N/A
JPMorgan Equity Premium Income C

ADAG and Stocks

Correlation & Price change

A.I.dvisor tells us that ADAG and ENTA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and ENTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
N/A
ENTA - ADAG
25%
Poorly correlated
-0.94%
IBO - ADAG
25%
Poorly correlated
+10.45%
CRDF - ADAG
23%
Poorly correlated
+1.14%
NAMS - ADAG
23%
Poorly correlated
-4.67%
CYBN - ADAG
22%
Poorly correlated
+6.33%
More